Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies

by Academia, E.C, Jia, L.Y, Lee, J., Mejías-De Jesús, C.M, Patel, C., Stevens, J.S, Yankama, T.
Published 2021

Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy

by Dura, J., Geyer, K., Lam, S.W, Lankford, C., Naelitz, B., Tran, A., Willner, M.
Published 2021

Evaluation of financial outcomes under a value-based payment program for community pharmacies

by DeVolder, R., Doucette, W.R, Heggen, T.
Published 2021

Assessment of hemp oil–based cannabidiol use in a community-based pharmacy setting

by Gatewood, S.S, Gicewicz, E., Goode, J.-V.R, Kaefer, T.N, Nadpara, P.
Published 2021

Applicability of a new specialty pharmacy-reported measure describing completion of therapy for hepatitis C

by Bolduc, C., Gelinas, A., Levesque, E., McCall, K., Stickney, K.
Published 2021

Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies

by Canfield, S., Carter, J., Choi, L., Cowgill, N., Declercq, J., Dura, J., Gazda, N.P, Gerzenshtein, L., Kehasse, A., Lach, M., Lee, J., Lewis, K., Lounsbery, B., Mccarthy, K., Ortega, M., Shah, R., Sokos, L., Stutsky, M., Thomas, K.C, Thomas, T.T, Wise, K., Young, J., Zuckerman, A.D
Published 2021

Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh

by Amin, M.N, Dewan, S.M.R, Islam, M.S, Khan, T.M, Ming, L.C, Moghal, M.R
Published 2016

Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy

by Banks, A., Choi, L., DeClercq, J., Givens, G., Markley, B., Peter, M.E, Zuckerman, A.D
Published 2021

Australian community pharmacists' perceptions of public health before the COVID-19 pandemic

by Clements, J., Day, G., Hattingh, H.L, Hope, D.L
Published 2021

Prevalence of statin utilization and adherence among privately insured subjects in the Commonwealth of Puerto Rico

by Hernández-Muñoz, J.J, Kamdar, C.R, Wong, E.S
Published 2021

The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia

by Brown, J.D, Raju, A., Schroader, B., Spargo, A., Squires, P., Yost, C.
Published 2021

Factors Associated with Opioid Overdose after an Initial Opioid Prescription

by Boyer, E.W, El Ibrahimi, S., Fischer, M.A, Flores, D.P, Hallvik, S.E, Hendricks, M.A, Hildebran, C., Kreiner, P.W, Ritter, G.A, Weiner, S.G, Weiss, R.D, Wright, D.A
Published 2022

Economic and clinical outcomes of pegfilgrastim via prefilled syringe vs on-body injector: A real-world data analysis

by Campbell, D., Campbell, K., Li, E., McBride, A., Schroader, B., Wang, W.
Published 2021

Impact of a diabetes remote monitoring program on medication adherence

by Amelung, K., Carter, C.S, Henderson, R.R, James, R., Munshi, K.D, Shah, B.R
Published 2021

Effect of the ExactCare medication care management model on adherence, health care utilization, and costs

by Chen, A.Y, Liu, H.H, Rose, A.J, Shetty, K.D
Published 2021

Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy

by Palli, S.R, Shaikh, A., Willey, V.J, Zhou, S.
Published 2021

Development and validation of a drug adherence index for COPD

by Bancroft, T., Bengtson, L.G.S, Buikema, A.R, Schilling, C., Stanford, R.H
Published 2021

Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States

by Ewenstein, B., Farahbakhshian, S., Lu, M., Oladapo, A., Wu, Y.
Published 2021

Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies

by Bengtson, L.G.S, Chastek, B., Palli, S.R, Xie, B.
Published 2021

Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: A retrospective observational s...

by Afdhal, N.H, Curry, M.P, Flamm, S.L, Milligan, S., Tsai, N., Wick, N., Younossi, Z.
Published 2021